Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase 2 trial of etonogestrel-releasing intrauterine system versus copper IUD
2009-012121-11Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of etonogestrel (4 arms), sponsored by Merck & Co. Primary endpoints: Safety of ENG-MIUS versus copper IUD, Acceptability of ENG-MIUS versus copper IUD and 1 more. Started Aug 2009; status: completed.
02
Drugs
etonogestrel
Beyond the preview
Go deeper on 2009-012121-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012121-11.